We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Priority Paper Evaluation

NaV1.5 and interacting proteins in human arrhythmogenic cardiomyopathy

    Ludovic Gillet

    Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland

    Search for more papers by this author

    ,
    Diana Shy

    Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland

    Search for more papers by this author

    &
    Hugues Abriel

    * Author for correspondence

    Department of Clinical Research, Ion Channel Research Group, University of Bern, Murtenstrasse 35, 3010 Bern, Switzerland.

    Search for more papers by this author

    Email the corresponding author at hugues.abriel@dkf.unibe.ch

    Published Online:8 Jul 2013https://doi.org/10.2217/fca.13.38

    Abstract

    Evaluation of: Noorman M, Hakim S, Kessler E et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm 10(3), 412–419 (2013). Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease characterized by a progressive replacement of the ventricular myocardium with adipose and fibrous tissue. This disease is often associated with mutations in genes encoding desmosomal proteins in the majority of patients. Based on results obtained from recent experimental models, a disturbed distribution of gap junction proteins and cardiac sodium channels may also be observed in AC phenotypes, secondary to desmosomal dysfunction. The study from Noorman et al. examined heart sections from patients diagnosed with AC and performed immunohistochemical analyses of N-cadherin, PKP2, PKG, Cx43 and the cardiac sodium channel NaV1.5. Altered expression/distribution of Cx43, PKG and NaV1.5 was found in most cases of patients with AC. The altered expression and/or distribution of NaV1.5 channels in AC hearts may play a mechanistic role in the arrhythmias leading to sudden cardiac death in AC patients. Thus, NaV1.5 should be considered as a supplemental element in the evaluation of risk stratification and management strategies. However, additional experiments are required to clearly understand the mechanisms leading to AC phenotypes.

    References

    • 1  Basso C, Bauce B, Corrado D, Thiene G. Pathophysiology of arrhythmogenic cardiomyopathy. Nat. Rev. Cardiol.9(4),223–233 (2012).
      CASGoogle Scholar
    • 2  Noorman M, van der Heyden MA, van Veen TA et al. Cardiac cell–cell junctions in health and disease: electrical versus mechanical coupling. J. Mol. Cell. Cardiol.47(1),23–31 (2009).
      Medline CASGoogle Scholar
    • 3  Jansen JA, Noorman M, Musa H et al. Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice. Heart Rhythm9(4),600–607 (2012).
      MedlineGoogle Scholar
    • 4  Sato PY, Musa H, Coombs W et al. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ. Res.105(6),523–526 (2009).
      Medline CASGoogle Scholar
    • 5  Noorman M, Hakim S, Kessler E et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm10(3),412–419 (2013).
      MedlineGoogle Scholar
    • 6  Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur. Heart J.31(7),806–814 (2010).
      MedlineGoogle Scholar
    • 7  Paul M, Wichter T, Fabritz L, Waltenberger J, Schulze-Bahr E, Kirchhof P. Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification. Herzschrittmacherther. Elektrophysiol.23(3),186–195 (2012).
      Medline CASGoogle Scholar
    • 8  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N. Engl. J. Med.321(6),406–412 (1989).
      MedlineGoogle Scholar
    • 9  Sato PY, Coombs W, Lin X et al. Interactions between ankyrin-G, plakophilin-2, and connexin43 at the cardiac intercalated disc. Circ. Res.109(2),193–201 (2011).
      Medline CASGoogle Scholar
    • 10  Shy D, Gillet L, Abriel H. Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model. Biochim. Biophys. Acta1833(4),886–894 (2013).
      Medline CASGoogle Scholar
    • 11  Rhett JM, Gourdie RG. The perinexus: a new feature of Cx43 gap junction organization. Heart Rhythm9(4),619–623 (2012).
      MedlineGoogle Scholar
    • 12  Rhett JM, Veeraraghavan R, Poelzing S, Gourdie RG. The perinexus: sign-post on the path to a new model of cardiac conduction? Trends Cardiovasc. Med. doi:10.1016/j.tcm.2012.12.005 (2013) (Epub ahead of print).
      MedlineGoogle Scholar
    • 13  Hunter AW, Barker RJ, Zhu C, Gourdie RG. Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. Mol. Biol. Cell16(12),5686–5698 (2005).
      Medline CASGoogle Scholar
    • 14  Gullberg M, Andersson AC. Visualization and quantification of protein–protein interactions in cells and tissues. Nat. Methods7,5–6 (2010).
      MedlineGoogle Scholar
    • 15  Petitprez S, Zmoos AF, Ogrodnik J et al. SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes. Circ. Res.108(3),294–304 (2011).
      Medline CASGoogle Scholar
    • 16  Stein M, van Veen TA, Remme CA et al. Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction. Cardiovasc. Res.83(1),52–60 (2009).
      Medline CASGoogle Scholar
    • 17  Verkerk AO, van Ginneken AC, van Veen TA, Tan HL. Effects of heart failure on brain-type Na+ channels in rabbit ventricular myocytes. Europace9(8),571–577 (2007).
      MedlineGoogle Scholar
    • 18  Milstein ML, Musa H, Balbuena DP et al. Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia. Proc. Natl Acad. Sci. USA109(31),e2134–e2143 (2012).
      Medline CASGoogle Scholar